<DOC>
	<DOC>NCT01012687</DOC>
	<brief_summary>The objective of this study was to prove the bioequivalence of Perindopril Erbumine 8 mg tablets under fasting conditions.</brief_summary>
	<brief_title>Bioequivalency Study of Perindopril Erbumine 8 mg Tablet Under Fasted Conditions</brief_title>
	<detailed_description />
	<mesh_term>Perindopril</mesh_term>
	<criteria>No clinically significant abnormal findings on the physical examination, medical history, or clinical laboratory results during screening Positive test for HIV, Hepatitis B, or Hepatitis C. Treatment with known enzyme altering drugs. History of allergic or adverse response to perindopril or any comparable or similar product.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2009</verification_date>
</DOC>